scholarly article | Q13442814 |
P50 | author | Craig Jin | Q86496350 |
P2093 | author name string | Wojciech Chrzanowski | |
Wu Shun Felix Wong | |||
Priyanka Tharkar | |||
Ramya Varanasi | |||
P2860 | cites work | Focused ultrasound treatment for central nervous system disease: neurosurgeon's perspectives | Q90856041 |
Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability | Q90977985 | ||
Low-Intensity Ultrasound Induces Thermodynamic Phase Separation of Cell Membranes through a Nucleation-Condensation Process | Q91656178 | ||
The role of cytokines in the regulation of NK cells in the tumor environment | Q91740314 | ||
Advances in the strategies for designing receptor-targeted molecular imaging probes for cancer research | Q91760110 | ||
Which Parameters Affect Biofilm Removal with Acoustic Cavitation? A Review | Q91812517 | ||
The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data | Q92496382 | ||
Penetration of different molecule sizes upon ultrasound combined with microbubbles in a superficial tumour model | Q92496912 | ||
Sono-Immunotherapeutic Nanocapturer to Combat Multidrug-Resistant Bacterial Infections | Q92925962 | ||
Ultrasound-Responsive Polymeric Micelles for Sonoporation-Assisted Site-Specific Therapeutic Action | Q48351171 | ||
Science to practice: opening the blood-brain barrier with focused ultrasound-a potential treatment for Alzheimer disease? | Q48448695 | ||
High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo | Q48621051 | ||
Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules. | Q48671776 | ||
High-intensity focused ultrasound in the treatment of breast tumours | Q49538226 | ||
Combined use of nanocarriers and physical methods for percutaneous penetration enhancement | Q50051045 | ||
High intensity focused ultrasound hyperthermia for enhanced macromolecular delivery | Q50196420 | ||
Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study | Q50239455 | ||
Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound | Q50239562 | ||
Nanoparticle-enhanced synergistic HIFU ablation and transarterial chemoembolization for efficient cancer therapy. | Q50240562 | ||
Ultrasound responsive block copolymer micelle of poly(ethylene glycol)-poly(propylene glycol) obtained through click reaction | Q50240717 | ||
High intensity focused ultrasound therapy resulted in a complete response in a patient with advanced gastric cancer with liver metastases: a case report | Q50248458 | ||
Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment | Q50248992 | ||
Model for Porosity Changes Occurring during Ultrasound-Enhanced Transcorneal Drug Delivery | Q50778322 | ||
Analytic models for mechanotransduction: gating a mechanosensitive channel | Q24633961 | ||
The Smart Drug Delivery System and Its Clinical Potential | Q26744837 | ||
Clinical applications of low-intensity pulsed ultrasound and its potential role in urology | Q26747657 | ||
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective | Q26748018 | ||
Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects | Q26777688 | ||
Local tumour hyperthermia as immunotherapy for metastatic cancer | Q26823968 | ||
Ultrasound enhanced drug delivery to the brain and central nervous system | Q26991618 | ||
Ultrasound microbubble contrast agents for diagnostic and therapeutic applications : current status and future design | Q27023635 | ||
Novel targeted bladder drug-delivery systems: a review | Q27027696 | ||
Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
Ultrasound triggered release of cisplatin from liposomes in murine tumors | Q28238830 | ||
Tumor Ablation and Nanotechnology | Q28385067 | ||
Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas | Q28574605 | ||
MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound | Q30252977 | ||
A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor | Q30276072 | ||
Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. | Q30358121 | ||
Enhancement of Small Molecule Delivery by Pulsed High-Intensity Focused Ultrasound: A Parameter Exploration. | Q30360051 | ||
Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment. | Q30362004 | ||
Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. | Q30363372 | ||
Multiparameter evaluation of in vivo gene delivery using ultrasound-guided, microbubble-enhanced sonoporation | Q30363593 | ||
Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs | Q30367369 | ||
Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities. | Q30382852 | ||
Nanodroplet-Vaporization-Assisted Sonoporation for Highly Effective Delivery of Photothermal Treatment. | Q30385124 | ||
Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer | Q30386140 | ||
State-of-the-art materials for ultrasound-triggered drug delivery | Q30409234 | ||
Therapeutic potential of low-intensity ultrasound (part 1): thermal and sonomechanical effects | Q38859630 | ||
Ultrasound-mediated ocular delivery of therapeutic agents: a review. | Q38867140 | ||
High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities | Q38990675 | ||
Ultrasound Enhances the Efficacy of Chlorin e6-Mediated Photodynamic Therapy in MDA-MB-231 Cells | Q39129835 | ||
Membrane damage effect of continuous wave ultrasound on K562 human leukemia cells | Q39235497 | ||
Effect of oxidative stress on plasma membrane fluidity of THP-1 induced macrophages | Q39287066 | ||
Ultrasound-guided drug delivery in cancer. | Q39368014 | ||
Perfluorohexane‐Encapsulated Mesoporous Silica Nanocapsules as Enhancement Agents for Highly Efficient High Intensity Focused Ultrasound (HIFU) | Q39416590 | ||
The role of bacterial biofilms in chronic infections | Q39426830 | ||
Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. | Q39460702 | ||
Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat | Q39483229 | ||
Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury | Q39534516 | ||
Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. | Q40029428 | ||
Low-intensity ultrasound-exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BK(Ca) channels | Q40054105 | ||
Mechanistic Insight into Sonoporation with Ultrasound-Stimulated Polymer Microbubbles | Q40067662 | ||
Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide | Q40288632 | ||
Therapeutic ultrasound optimization for gene delivery: a key factor achieving nuclear DNA localization | Q40359026 | ||
Liposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody. | Q40474929 | ||
In situ tumor ablation creates an antigen source for the generation of antitumor immunity | Q40550098 | ||
Low-frequency ultrasound for drug delivery in the gastrointestinal tract | Q40966135 | ||
Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model. | Q41893433 | ||
Thalamotomy for essential tremor: FDA approval brings brain treatment with FUS to the clinic | Q42333459 | ||
Current and emerging brain applications of MR-guided focused ultrasound | Q42371224 | ||
Ultrasound well below the intensity threshold of cavitation can promote efficient uptake of small drug model molecules in fibroblast cells. | Q42813260 | ||
Ultrasonic nebulization system for respiratory drug delivery | Q43541410 | ||
Intracellular drug delivery using low-frequency ultrasound: quantification of molecular uptake and cell viability | Q43834984 | ||
Ocular drug delivery using 20-kHz ultrasound | Q44061360 | ||
The cell membrane as a biosensor of oxidative stress induced by radiation exposure: a multiparameter investigation | Q44366447 | ||
Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial | Q45071354 | ||
Neuronavigation-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening: A Preliminary Study in Swine | Q45098426 | ||
A Review of the Combination Therapy of Low Frequency Ultrasound with Antibiotics | Q45788097 | ||
Use of ultrasound to enhance nonviral lung gene transfer in vivo | Q45866017 | ||
Monitoring the effect of sonoporation on the cells using electrochemical approach. | Q45874467 | ||
Binding and interstitial penetration of liposomes within avascular tumor spheroids. | Q45878088 | ||
Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes | Q45879465 | ||
Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. | Q45880567 | ||
High-frequency ultrasound-responsive block copolymer micelle. | Q45942518 | ||
Intermittent watt-level ultrasonication facilitates vancomycin release from therapeutic acrylic bone cement | Q46193774 | ||
Construction of Homogenous/Heterogeneous Hollow Mesoporous Silica Nanostructures by Silica-Etching Chemistry: Principles, Synthesis, and Applications | Q46314209 | ||
Mechanistic understanding the bioeffects of ultrasound-driven microbubbles to enhance macromolecule delivery | Q47197349 | ||
Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study | Q47201025 | ||
Targeting microbial biofilms: current and prospective therapeutic strategies. | Q47637669 | ||
Effect of high intensity focused ultrasound (HIFU) in conjunction with a nanomedicines-microbubble complex for enhanced drug delivery | Q47657482 | ||
Crossing the blood-brain barrier with nanoparticles | Q47900736 | ||
Non-invasive assessment and control of ultrasound-mediated membrane permeabilization | Q47909222 | ||
Ultrasound processing of liquid system(s) and its antimicrobial mechanism of action. | Q47963906 | ||
Ultrasound-sensitive nanoparticle aggregates for targeted drug delivery | Q48015813 | ||
Ultrasound-based triggered drug delivery to tumors. | Q48047324 | ||
Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors | Q30422904 | ||
Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors | Q30426788 | ||
Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy | Q30426880 | ||
Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications | Q30429594 | ||
Ultrasound-mediated local drug and gene delivery using nanocarriers. | Q30431194 | ||
Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology | Q30434475 | ||
Bactericidal effect of hydroxyl radicals generated from a low concentration hydrogen peroxide with ultrasound in endodontic treatment | Q30437317 | ||
Overview of therapeutic ultrasound applications and safety considerations | Q30447970 | ||
Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer | Q30450131 | ||
Spatiotemporally controlled single cell sonoporation | Q30455582 | ||
Intracellular delivery and calcium transients generated in sonoporation facilitated by microbubbles | Q30476853 | ||
Driving delivery vehicles with ultrasound | Q30483826 | ||
High-intensity focused ultrasound therapy: an overview for radiologists | Q30491226 | ||
Ultrasound-induced calcium oscillations and waves in Chinese hamster ovary cells in the presence of microbubbles | Q30493487 | ||
Three-MHz Ultrasound Heats Deeper Into the Tissues Than Originally Theorized. | Q30500795 | ||
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model | Q30502120 | ||
Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading | Q30502398 | ||
Ultrasonic drug delivery--a general review | Q30502960 | ||
Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis | Q30503506 | ||
Ultrasound Increases Nanoparticle Delivery by Reducing Intratumoral Pressure and Increasing Transport in Epithelial and Epithelial–Mesenchymal Transition Tumors | Q30514138 | ||
Emerging HIFU applications in cancer therapy | Q30867165 | ||
Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery | Q30984866 | ||
Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies | Q31063540 | ||
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
MR-guided focused ultrasound: a potentially disruptive technology | Q33475421 | ||
Tumor escape from immune surveillance | Q33593479 | ||
Overcoming Biological Barriers with Ultrasound | Q33618320 | ||
Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects | Q34030709 | ||
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells | Q34315871 | ||
Thermal ablation of tumours: biological mechanisms and advances in therapy. | Q34406134 | ||
Therapeutic ultrasound: its application in drug delivery | Q34540070 | ||
Oxidative stress and apoptosis: impact on cancer therapy. | Q34642005 | ||
Novel temperature-triggered liposome with high stability: Formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU) | Q34774300 | ||
Free radical formation induced by ultrasound and its biological implications | Q35232001 | ||
Ultrasound Effect on Cancerous versus Non-Cancerous Cells. | Q50862360 | ||
Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice | Q51044431 | ||
Recent advances in ultrasound-triggered therapy | Q52586265 | ||
Strategies to improve tumor penetration of nanomedicines through nanoparticle design | Q52586348 | ||
Progress and challenges towards targeted delivery of cancer therapeutics | Q52590993 | ||
Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters | Q52678238 | ||
Advanced Ultrasound Technologies for Diagnosis and Therapy. | Q52678316 | ||
Focused Ultrasound-Augmented Delivery of Biodegradable Multifunctional Nanoplatforms for Imaging-Guided Brain Tumor Treatment | Q52714308 | ||
Pre-Treatment with Either L-Carnitine or Piracetam Increases Ultrasound-Mediated Gene Transfection by Reducing Sonoporation-Associated Apoptosis. | Q52726026 | ||
Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update. | Q55056251 | ||
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery. | Q55348014 | ||
Effect of Molecular Weight on Sonoporation-Mediated Uptake in Human Cells | Q57067820 | ||
A Review of Thermo- and Ultrasound-Responsive Polymeric Systems for Delivery of Chemotherapeutic Agents | Q57372291 | ||
Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation | Q57789371 | ||
INTRAVASCULAR ULTRASOUND ANGIOPLASTY IN PERIPHERAL ARTERIAL OCCLUSION: Preliminary experience | Q58281808 | ||
Magnetic Resonance-Guided Focused Ultrasound : Current Status and Future Perspectives in Thermal Ablation and Blood-Brain Barrier Opening | Q60923907 | ||
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches | Q61446826 | ||
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients | Q61804477 | ||
Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model | Q64066363 | ||
Ultrasound-guided high-intensity focused ultrasound in the treatment of uterine fibroids | Q64116532 | ||
Ultrasound Hyperthermia Technology for Radiosensitization | Q64232827 | ||
Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. | Q64892339 | ||
Sonodynamic Therapy With Anticancer Micelles and High-Intensity Focused Ultrasound in Treatment of Canine Cancer. | Q64898485 | ||
Measurement of cytoplasmic pH in Dictyostelium discoideum by using a new method for introducing macromolecules into living cells | Q69512413 | ||
Use of therapeutic ultrasound in percutaneous coronary angioplasty. Experimental in vitro studies and initial clinical experience | Q72344124 | ||
Iron-induced lipid peroxidation and protein modification in endoplasmic reticulum membranes. Protection by stobadine | Q73591294 | ||
Evaluation of the efficacy of therapeutic ultrasound on bone mineral density in postmenopausal period | Q81230097 | ||
Therapeutic ultrasound angioplasty: the risk of arterial perforation. An in vitro study | Q84987878 | ||
Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes | Q87711567 | ||
High intensity focused ultrasound: The fundamentals, clinical applications and research trends | Q88736485 | ||
Combination of chemotherapy and photodynamic therapy for cancer treatment with sonoporation effects | Q89049314 | ||
Advances in mechanism studies on ultrasonic gene delivery at cellular level | Q90385225 | ||
Nanoparticles in the clinic: An update | Q90404021 | ||
Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy | Q90420020 | ||
Mesoporous silica nanoparticles for therapeutic/diagnostic applications | Q90511470 | ||
Low-frequency ultrasound may improve drug penetration in colonic mucosa | Q90731392 | ||
Enhanced drug delivery using sonoactivatable liposomes with membrane-embedded porphyrins | Q90740914 | ||
Systematic review of high-intensity focused ultrasound ablation in the treatment of breast cancer. | Q35669836 | ||
Therapeutic applications of lipid-coated microbubbles. | Q35756608 | ||
Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy | Q36480244 | ||
The synaptic vesicle: cycle of exocytosis and endocytosis. | Q36481260 | ||
Therapeutic applications of ultrasound | Q36576111 | ||
Mitochondria and reactive oxygen species in renal cancer. | Q36804989 | ||
Host antitumour immune responses to HIFU ablation | Q36853082 | ||
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. | Q36933039 | ||
Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes | Q37013422 | ||
High-intensity focused ultrasound: current potential and oncologic applications | Q37038156 | ||
Principles of nanoparticle design for overcoming biological barriers to drug delivery | Q37162182 | ||
Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus | Q37280337 | ||
Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions | Q37314655 | ||
Cancer cell killing via ROS: to increase or decrease, that is the question | Q37316371 | ||
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes | Q37585670 | ||
The role of Ca2+ in ultrasound-elicited bioeffects: progress, perspectives and prospects | Q37781506 | ||
The characterization of acoustic cavitation bubbles – An overview | Q37822569 | ||
Therapeutic ultrasound an overview. | Q37840664 | ||
Synergistic bactericidal effects and mechanisms of low intensity ultrasound and antibiotics against bacteria: A review | Q37849701 | ||
Free radical formation by ultrasound in aqueous solutions. A spin trapping study | Q37887413 | ||
Lipid peroxidation modifies the picture of membranes from the “Fluid Mosaic Model” to the “Lipid Whisker Model” | Q37943608 | ||
Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. | Q37995276 | ||
Ultrasound-induced cell permeabilisation and hyperthermia: Strategies for local delivery of compounds with intracellular mode of action | Q38012536 | ||
Stimulus-responsive nanopreparations for tumor targeting | Q38032480 | ||
Microbial biofilm modulation by ultrasound: current concepts and controversies. | Q38113355 | ||
Understanding ultrasound induced sonoporation: definitions and underlying mechanisms | Q38165638 | ||
Cell experimental studies on sonoporation: state of the art and remaining problems | Q38167557 | ||
Barriers to drug delivery in solid tumors | Q38234567 | ||
Ultrasonically triggered drug delivery: breaking the barrier. | Q38278230 | ||
Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care | Q38286844 | ||
Strategies for combating bacterial biofilm infections | Q38287542 | ||
Focused Ultrasound and Lithotripsy | Q38612525 | ||
Ultrasound-Mediated Polymeric Micelle Drug Delivery | Q38612549 | ||
Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin | Q38714172 | ||
Influence of tumor cell lines derived from different tissue on sonoporation efficiency under ultrasound microbubble treatment | Q38750014 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | drug delivery | Q1392806 |
nanotechnology | Q11468 | ||
P304 | page(s) | 324 | |
P577 | publication date | 2019-11-22 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Frontiers in Bioengineering and Biotechnology | Q21971197 |
P1476 | title | Nano-Enhanced Drug Delivery and Therapeutic Ultrasound for Cancer Treatment and Beyond | |
P478 | volume | 7 |
Q99632062 | Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective |
Q98771567 | Recent Advances in Micro-Electro-Mechanical Devices for Controlled Drug Release Applications |
Q98497959 | Ultrasound-Mediated Delivery of Chemotherapy into the Transgenic Adenocarcinoma of the Mouse Prostate Model |